Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-053165)

Filing Details

Accession Number:: 0001209191-20-053165
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-02 16:34:33
Reporting Period:: 2020-09-30

Accepted Time:: 2020-10-02 16:34:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178879	Amicus Therapeutics Inc.	FOLD	Pharmaceutical Preparations (2834)	200422823

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601896	Jay Barth	C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-30	4,064	$2.29	167,268	No	4	M	Direct
Common Stock	Disposition	2020-09-30	4,064	$14.51	163,204	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2020-09-30	4,064	$0.00	4,064	$2.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,666		2024-03-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20	Indirect	By Daughter

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
All of the options were fully vested and exercisable as of the transaction date.